cardiac glycoside derivatives (Weizmann)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namecardiac glycoside derivatives (Weizmann)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium/potassium-transporting ATPase inhibitors
TargetsSodium/potassium-transporting ATPase
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWeizmann Institute Of Science
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYeda Research and Development Co LtdWeizmann Institute Of Science
Active IndicationsN/A
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A